Mustang Bio Inc (MBIO)
0.1356
-0.01
(-8.69%)
USD |
NASDAQ |
Jun 10, 16:00
0.1338
0.00 (0.00%)
After-Hours: 06:11
Mustang Bio Cash from Financing (Quarterly): 0.049M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.049M |
| December 31, 2023 | 3.956M |
| September 30, 2023 | 0.25M |
| June 30, 2023 | -30.29M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.001M |
| September 30, 2022 | 0.80M |
| June 30, 2022 | 3.034M |
| March 31, 2022 | 30.22M |
| December 31, 2021 | 4.919M |
| September 30, 2021 | 3.235M |
| June 30, 2021 | 15.09M |
| March 31, 2021 | 47.60M |
| December 31, 2020 | 33.49M |
| September 30, 2020 | 1.622M |
| June 30, 2020 | 37.93M |
| March 31, 2020 | 5.079M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.111M |
| June 30, 2019 | 51.61M |
| March 31, 2019 | 13.61M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.085M |
| March 31, 2018 | 0.096M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.062M |
| June 30, 2017 | -0.008M |
| March 31, 2017 | 49.92M |
| December 31, 2016 | 18.64M |
| September 30, 2016 | 11.68M |
| June 30, 2016 | 0.72M |
| March 31, 2016 | 0.581M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-30.29M
Minimum
Jun 2023
51.61M
Maximum
Jun 2019
10.42M
Average
3.134M
Median
Cash from Financing (Quarterly) Benchmarks
| Fortress Biotech Inc | 27.86M |
| Avinger Inc | 6.633M |
| AIM ImmunoTech Inc | 2.829M |
| Protalix BioTherapeutics Inc | 0.00 |
| Armata Pharmaceuticals Inc | 34.93M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.321M |
| Free Cash Flow | -36.99M |
| Free Cash Flow Per Share (Quarterly) | -0.4728 |
| Free Cash Flow Yield | -2.90K% |